ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > PAR1

PAR1

概要

Name:Protease-activated receptor-1
Target Synonym:Coagulation Factor II (Thrombin) Receptor,Proteinase-Activated Receptor 1,Coagulation Factor II Receptor,Protease-Activated Receptor 1,Protease Activated Receptor 1,Thrombin Receptor,HTR,Receptor, PAR-1,PAR1,F2R,Coagulation Factor II Thrombin Receptor,PAR-1,CF2R,TR
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Approved

製品リスト製品比較と製品注文

製品仕様別:
製品カテゴリー別:
種類別:
コンジュゲート:
製造番号 種類 製品説明 構造 純度 特徴
PA1-HF2G5 Human Fluorescent Human PAR1 Full Length Protein (VLP)
PA1-H52P6 Human Human PAR1 Full Length Protein (VLP)
ACRO Quality

生物活性データの一部

PA1-H52P6-ELISA
 PAR1 ELISA

Immobilized Human PAR1 Full Length Protein-VLP (Cat. No. PA1-H52P6) at 5 μg/mL (100 μL/well) can bind Monoclonal Anti-Human PAR1 antibody, Mouse IgG1 with a linear range of 0.1-1.3 μg/mL (QC tested).

PA1-HF2G5-ELISA
 PAR1 ELISA

Immobilized Fluorescent Human PAR1 Full Length Protein (VLP) (Cat. No. PA1-HF2G5) at 5 μg/mL (100 μL/well) can bind Monoclonal Anti-PAR1 Antibody (Mouse IgG) with a linear range of 0.6-10 ng/mL (QC tested).

公開薬物情報

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Vorapaxar Sulfate MK-5348; TRA-SCH-530348; SCH-530348 Approved Merck Sharp & Dohme Corp Zontivity United States Coronary Thrombosis; Myocardial Infarction; Peripheral Arterial Disease; Thrombosis Xspire Pharma 2014-05-08 Myocardial Ischemia; Myocardial Infarction; Atherosclerosis; Arterial Occlusive Diseases; Stroke; Acute Coronary Syndrome; Coronary Thrombosis; Coronary Disease; Arteriovenous Fistula; Ischemia; Peripheral Arterial Disease; Thrombosis; Cerebral Infarction Details
Vorapaxar Sulfate MK-5348; TRA-SCH-530348; SCH-530348 Approved Merck Sharp & Dohme Corp Zontivity United States Coronary Thrombosis; Myocardial Infarction; Peripheral Arterial Disease; Thrombosis Xspire Pharma 2014-05-08 Myocardial Ischemia; Myocardial Infarction; Atherosclerosis; Arterial Occlusive Diseases; Stroke; Acute Coronary Syndrome; Coronary Thrombosis; Coronary Disease; Arteriovenous Fistula; Ischemia; Peripheral Arterial Disease; Thrombosis; Cerebral Infarction Details

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
PZ-128 PZ-128 Phase 2 Clinical Tufts Medical Center Inc Myocardial Ischemia; Arterial Occlusive Diseases; Heart Diseases; Coronary Artery Disease; Acute Coronary Syndrome; Vascular Diseases; Coronary Disease; Arteriosclerosis Details
Rusalatide TRAP-508; TP-508 Phase 1 Clinical Baylor College Of Medicine, University Of Texas Medical Branch Respiratory Distress Syndrome, Adult; Radius Fractures Details
PZ-128 PZ-128 Phase 2 Clinical Tufts Medical Center Inc Myocardial Ischemia; Arterial Occlusive Diseases; Heart Diseases; Coronary Artery Disease; Acute Coronary Syndrome; Vascular Diseases; Coronary Disease; Arteriosclerosis Details
Rusalatide TRAP-508; TP-508 Phase 1 Clinical Baylor College Of Medicine, University Of Texas Medical Branch Respiratory Distress Syndrome, Adult; Radius Fractures Details

This web search service is supported by Google Inc.

totopphone